• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因使用雄激素剥夺疗法导致非持续尖端扭转型室性心动过速引起晕厥:病例报告。

Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation.

机构信息

School of Medicine and Health Sciences, Internal Medicine Program, Fundación Cardioinfantil, Universidad del Rosario, Carrera 24 #63C-69, Bogotá, Colombia.

Fundación Cardioinfantil, Universidad del Bosque, Bogotá, Colombia.

出版信息

BMC Cardiovasc Disord. 2021 Mar 12;21(1):136. doi: 10.1186/s12872-021-01945-3.

DOI:10.1186/s12872-021-01945-3
PMID:33711933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7953541/
Abstract

BACKGROUND

Abiraterone is a medication frequently used for metastatic castrate-resistant prostate cancer. We report a case of non-sustained episodes of TdP associated with severe hypokalemia due to androgen-deprivation therapy. Few case presentations describe this association; the novelty lies in the potentially lethal cardiovascular events among cancer patients receiving hormonal therapy.

CASE PRESENTATION

A 70-year-old male presented with recurrent syncope without prodrome. ECG revealed frequent ventricular ectopy, non-sustained episodes of TdP, and severe hypomagnesemia and hypokalemia. During potassium and magnesium infusion for repletion, the patient underwent temporary transvenous atrial pacing. As part of the work-up, coronary angiography revealed a mild coronary artery disease, and transthoracic echocardiogram showed a moderately depressed ejection fraction. After electrolyte disturbances were corrected, the QT interval normalized, and transvenous pacing was no longer necessary. Abiraterone was discontinued during the admission, and the patient returned to baseline.

CONCLUSIONS

Cancer treatment is complex and requires a multidisciplinary approach. We presented a case of non-sustained TdP associated with androgen-deprivation therapy in an elderly patient with mild coronary artery disease and moderately reduced ejection fraction. Close follow-up and increased awareness are required in patients with hormonal treatment, especially in the setting of other cardiovascular risk factors.

摘要

背景

阿比特龙是一种常用于转移性去势抵抗性前列腺癌的药物。我们报告了一例与雄激素剥夺治疗相关的严重低钾血症引起的非持续 Tdp 发作的病例。很少有病例报告描述这种关联;新颖之处在于接受激素治疗的癌症患者中潜在的致命性心血管事件。

病例介绍

一名 70 岁男性因反复晕厥无先兆而就诊。心电图显示频繁室性早搏、非持续 Tdp 发作和严重低镁血症和低钾血症。在进行补钾和补镁治疗时,患者接受了临时经静脉心房起搏。在检查过程中,冠状动脉造影显示轻度冠状动脉疾病,经胸超声心动图显示中度射血分数降低。电解质紊乱纠正后,QT 间期正常化,不再需要经静脉起搏。入院期间停用阿比特龙,患者恢复基线水平。

结论

癌症治疗复杂,需要多学科方法。我们报告了一例与雄激素剥夺治疗相关的非持续 Tdp 发作的病例,该病例发生在一名患有轻度冠状动脉疾病和中度射血分数降低的老年患者中。需要对接受激素治疗的患者进行密切随访和提高认识,尤其是在存在其他心血管危险因素的情况下。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc6/7953541/d0aa73578775/12872_2021_1945_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc6/7953541/adaa9b67cc89/12872_2021_1945_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc6/7953541/b53986b50dbe/12872_2021_1945_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc6/7953541/d0aa73578775/12872_2021_1945_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc6/7953541/adaa9b67cc89/12872_2021_1945_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc6/7953541/b53986b50dbe/12872_2021_1945_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc6/7953541/d0aa73578775/12872_2021_1945_Fig3_HTML.jpg

相似文献

1
Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation.因使用雄激素剥夺疗法导致非持续尖端扭转型室性心动过速引起晕厥:病例报告。
BMC Cardiovasc Disord. 2021 Mar 12;21(1):136. doi: 10.1186/s12872-021-01945-3.
2
[QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].[米安色林治疗期间的QT间期延长和尖端扭转型室性心动过速。鉴别诊断和治疗方面]
Dtsch Med Wochenschr. 2001 Dec 7;126(49):1396-400. doi: 10.1055/s-2001-18880.
3
[Drug induced QT prolongation].[药物诱导的QT间期延长]
Wien Klin Wochenschr. 2008;120(5-6):128-35. doi: 10.1007/s00508-008-0940-6.
4
Efficacy of ventricular pacing in the treatment of an arrhythmic storm associated with a congenital long QT mutation.心室起搏治疗与先天性长QT突变相关的心律失常风暴的疗效
Congenit Heart Dis. 2013 Nov-Dec;8(6):E165-7. doi: 10.1111/chd.12014. Epub 2012 Oct 18.
5
Peripartum cardiomyopathy presenting with syncope due to Torsades de pointes: a case of long QT syndrome with a novel KCNH2 mutation.因尖端扭转型室速导致晕厥的围产期心肌病:一例伴有新型KCNH2突变的长QT综合征病例
Intern Med. 2012;51(5):461-4. doi: 10.2169/internalmedicine.51.5943. Epub 2012 Mar 1.
6
Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study.男性长 QT 综合征伴尖端扭转型室性心动过速和性腺功能减退症的临床特征:一项综述和药物警戒研究。
Arch Cardiovasc Dis. 2019 Nov;112(11):699-712. doi: 10.1016/j.acvd.2019.06.008. Epub 2019 Aug 30.
7
QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: a case report and review of the literature.伏立诺他治疗患者出现 QT 间期延长和尖端扭转型室性心动过速:病例报告及文献复习。
Cardiol J. 2012;19(4):434-8.
8
Citalopram induced torsade de pointes, a rare life threatening side effect.西酞普兰诱发尖端扭转型室速,这是一种罕见的危及生命的副作用。
Int J Cardiol. 2008 Dec 17;131(1):e33-4. doi: 10.1016/j.ijcard.2007.08.006. Epub 2007 Oct 4.
9
Torsade de pointes caused by citalopram during the pacemaker battery-depletion phase: A case report.尖端扭转型室性心动过速由起搏器电池耗竭期的西酞普兰引起:一例报告。
Ann Noninvasive Electrocardiol. 2022 Jul;27(4):e12936. doi: 10.1111/anec.12936. Epub 2022 Mar 24.
10
Idiopathic long QT syndrome with late onset of bradycardia-dependent and short-coupled variant of torsade de pointes.特发性长QT综合征伴迟发性心动过缓依赖性及短联律间期尖端扭转型室速变异型
Int J Cardiol. 1998 Mar 13;64(1):93-5. doi: 10.1016/s0167-5273(97)00331-8.

引用本文的文献

1
Unplanned hospitalization among advanced prostate cancer patients by diabetes status: a population-based study.晚期前列腺癌患者因糖尿病状态导致的非计划性住院:一项基于人群的研究。
JNCI Cancer Spectr. 2025 Sep 1;9(5). doi: 10.1093/jncics/pkaf070.
2
Polymorphic ventricular tachycardia and cardiac arrest from abiraterone-induced hypokalemia: a case report.阿比特龙致低钾血症引起的多形性室性心动过速和心脏骤停:1 例报告。
J Med Case Rep. 2024 Apr 16;18(1):186. doi: 10.1186/s13256-024-04513-3.

本文引用的文献

1
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes.扭转型室速患者前列腺癌的雄激素剥夺治疗
Front Pharmacol. 2020 May 13;11:684. doi: 10.3389/fphar.2020.00684. eCollection 2020.
2
Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses.雄激素剥夺疗法治疗前列腺癌的心血管效应:当代荟萃分析。
Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):e55-e64. doi: 10.1161/ATVBAHA.119.313046. Epub 2020 Jan 23.
3
Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities.
口服雄激素信号抑制剂治疗合并心血管合并症的晚期前列腺癌男性患者的死亡率和住院风险。
Eur Urol. 2020 Feb;77(2):158-166. doi: 10.1016/j.eururo.2019.07.031. Epub 2019 Aug 13.
4
Risk of hypertension in cancer patients treated with abiraterone: a meta-analysis.阿比特龙治疗癌症患者的高血压风险:一项荟萃分析。
Clin Hypertens. 2019 Jun 1;25:12. doi: 10.1186/s40885-019-0116-x. eCollection 2019.
5
Emerging Arrhythmic Risk of Autoimmune and Inflammatory Cardiac Channelopathies.自身免疫性和炎性心脏离子通道病新出现的心律失常风险
J Am Heart Assoc. 2018 Nov 20;7(22):e010595. doi: 10.1161/JAHA.118.010595.
6
Hypogonadism as a Reversible Cause of Torsades de Pointes in Men.性腺功能减退作为男性尖端扭转型室速的可逆性病因
Circulation. 2018 Jul 3;138(1):110-113. doi: 10.1161/CIRCULATIONAHA.118.034282.
7
Androgen Deprivation Therapy Is Associated With Prolongation of QTc Interval in Men With Prostate Cancer.雄激素剥夺疗法与前列腺癌男性患者QTc间期延长有关。
J Endocr Soc. 2018 Apr 20;2(5):485-496. doi: 10.1210/js.2018-00039. eCollection 2018 May 1.
8
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer.阿比特龙和恩杂鲁胺在前列腺癌中的心血管毒性。
Clin Genitourin Cancer. 2018 Jun;16(3):e645-e653. doi: 10.1016/j.clgc.2017.12.007. Epub 2017 Dec 27.
9
Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review.癌症治疗相关的 QT 间期延长的发生率、诊断和处理:系统评价。
J Am Heart Assoc. 2017 Dec 7;6(12):e007724. doi: 10.1161/JAHA.117.007724.
10
Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials.阿比特龙或恩杂鲁胺治疗转移性去势抵抗性前列腺癌(mCRPC)患者的差异副作用概况:一项随机对照试验的荟萃分析。
Oncotarget. 2017 Aug 8;8(48):84572-84578. doi: 10.18632/oncotarget.20028. eCollection 2017 Oct 13.